<translate>  Di agency assure applicants say if Phase 3 clinical data dey very convincing and robust with regards to safety and efficacy, and di vaccine don dey submitted to WHO for Emergency Use Listing, NAFDAC go welcome di application for Emergency Use Authorisation in Nigeria. 